50 related articles for article (PubMed ID: 8293548)
1. Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s.
Styles JA; Davies A; Lim CK; De Matteis F; Stanley LA; White IN; Yuan ZX; Smith LL
Carcinogenesis; 1994 Jan; 15(1):5-9. PubMed ID: 8293548
[TBL] [Abstract][Full Text] [Related]
2. Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines (N-nitrosonornicotine and N-nitrosoanabasine) in human cells, partially different CYPs being activating enzymes.
Chen Y; Yang Z; Zhou Z; Liu EJ; Luo W; He Z; Han W; Liu Y
Toxicology; 2024 May; 504():153774. PubMed ID: 38490321
[TBL] [Abstract][Full Text] [Related]
3. Use of Lentivirus-Based Method for Establishing TK6 Human Cell Lines Expressing Cytochrome P450 and its Applications in Genotoxicity Testing.
Li X; Chen S; He X; Wu Q; Guo L; Mei N
Curr Protoc; 2024 Mar; 4(3):e1003. PubMed ID: 38483112
[TBL] [Abstract][Full Text] [Related]
4. An in vitro study on the genotoxic effect of substituted furans in cells transfected with human metabolizing enzymes: 2,5-dimethylfuran and furfuryl alcohol.
Huffman MP; Høie AH; Svendsen C; Brunborg G; Murkovic M; Glatt H; Husøy T
Mutagenesis; 2016 Sep; 31(5):597-602. PubMed ID: 27226491
[TBL] [Abstract][Full Text] [Related]
5. Contributions of human enzymes in carcinogen metabolism.
Rendic S; Guengerich FP
Chem Res Toxicol; 2012 Jul; 25(7):1316-83. PubMed ID: 22531028
[TBL] [Abstract][Full Text] [Related]
6. Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes.
Rendic SP; Guengerich FP
Arch Toxicol; 2024 Mar; ():. PubMed ID: 38520539
[TBL] [Abstract][Full Text] [Related]
7. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients.
Marie S; Frost KL; Hau RK; Martinez-Guerrero L; Izu JM; Myers CM; Wright SH; Cherrington NJ
Acta Pharm Sin B; 2023 Jan; 13(1):1-28. PubMed ID: 36815037
[TBL] [Abstract][Full Text] [Related]
8. Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
Rendic SP; Guengerich FP
Arch Toxicol; 2021 Feb; 95(2):395-472. PubMed ID: 33459808
[TBL] [Abstract][Full Text] [Related]
9. The Multifarious Link between Cytochrome P450s and Cancer.
Alzahrani AM; Rajendran P
Oxid Med Cell Longev; 2020; 2020():3028387. PubMed ID: 31998435
[TBL] [Abstract][Full Text] [Related]
10. Potential anti-genotoxic effect of sodium butyrate to modulate induction of DNA damage by tamoxifen citrate in rat bone marrow cells.
El-Shorbagy HM
Cytotechnology; 2017 Feb; 69(1):89-102. PubMed ID: 27905024
[TBL] [Abstract][Full Text] [Related]
11. Insights into CYP2B6-mediated drug-drug interactions.
Hedrich WD; Hassan HE; Wang H
Acta Pharm Sin B; 2016 Sep; 6(5):413-425. PubMed ID: 27709010
[TBL] [Abstract][Full Text] [Related]
12. Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.
Singh B; Bhat NK; Bhat HK
PLoS One; 2011; 6(9):e25125. PubMed ID: 21966433
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.
Yue J; Khokhar J; Miksys S; Tyndale RF
Eur J Pharmacol; 2009 May; 609(1-3):88-95. PubMed ID: 19285975
[TBL] [Abstract][Full Text] [Related]
14. CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.
Wang H; Tompkins LM
Curr Drug Metab; 2008 Sep; 9(7):598-610. PubMed ID: 18781911
[TBL] [Abstract][Full Text] [Related]
15. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.
Jordan VC
Steroids; 2007 Nov; 72(13):829-42. PubMed ID: 17765940
[TBL] [Abstract][Full Text] [Related]
16. Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity.
Coller JK; Krebsfaenger N; Klein K; Wolbold R; Nüssler A; Neuhaus P; Zanger UM; Eichelbaum M; Mürdter TE
Br J Clin Pharmacol; 2004 Jan; 57(1):105-11. PubMed ID: 14678348
[TBL] [Abstract][Full Text] [Related]
17. Dietary effects on drug metabolism and transport.
Harris RZ; Jang GR; Tsunoda S
Clin Pharmacokinet; 2003; 42(13):1071-88. PubMed ID: 14531721
[TBL] [Abstract][Full Text] [Related]
18. Species differences in the metabolic activation of tamoxifen into genotoxic derivatives: risk assessment in women.
De Matteis F; White IN; Smith LL
Eur J Drug Metab Pharmacokinet; 1998; 23(3):425-8. PubMed ID: 9842987
[TBL] [Abstract][Full Text] [Related]
19. Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site.
Mésange F; Sebbar M; Kedjouar B; Capdevielle J; Guillemot JC; Ferrara P; Bayard F; Delarue F; Faye JC; Poirot M
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):107-12. PubMed ID: 9693109
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer therapies in development. A review of their pharmacology and clinical potential.
de Valeriola D; Awada A; Roy JA; Di Leo A; Biganzoli L; Piccart M
Drugs; 1997 Sep; 54(3):385-413. PubMed ID: 9279502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
